Health · NZ ·

POP-DURVA: Short-Course Durvalumab Remodels the Immune Microenvironment but Rarely Produces pCR in Stage I TNB

Oncodaily · Health

Published

POP-DURVA: Short-Course Durvalumab Remodels the Immune Microenvironment but Rarely Produces pCR in Stage I TNB

Read it at the source

Oncodaily↗

We link out rather than republish. The reporting belongs to the publications above; the summary and the search data on this page are ours.

More trending now